Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)
Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 71205-468
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 71205-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)
This is a chart showing the concentration of Tramadol at different time intervals (in hours) after taking extended-release tablets of 200 mg once a day and regular tablets of 50 mg every 6 hours. The concentration is measured in nanograms per milliliter.*
Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)
This is a chart that shows the concentration of M1 in ng/mL over time (in hours) for two different drugs: Tramadol Hydrochloride Extended-Release Tablets (dosed once a day at 200mg) and Tramadol Hydrochloride Tablets (dosed every 6 hours at 50mg).*
Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)
This appears to be a graph showing the percentage of patients achieving various levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis. The study investigated the effectiveness of the tablets at different dosages (100mg, 200mg, 300mg, and 400mg) in reducing pain. The graph shows that a higher percentage of patients achieved a response with higher dosages of the tablets compared to placebo.*
Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)
This is a chart depicting the results of a study (Study 015) on the use of Tramadol Hydrochloride Extended-Release Tablets for the treatment of Arthritis Pain Intensity. The chart shows the percentage of patients who achieved various levels of response threshold, indicated as a percent improvement from baseline. The results are compared to a placebo group.*
71205-468-30 (33a5de83 A974 48a5 8ba6 4c1b97515615 07)
The text describes a medication named Tramadol HCI, which is an extended-release tablet with 200 mg of tramadol hydrochloride USP per tablet. It is manufactured by Lupin Limited in India and relabeled by Proficient Rx LP in California. It comes in a bottle of 30 tablets with beveled edges, and is imprinted with "LOT1" on one side and plain on the other side. The store temperature is indicated to be 26°C (77°F) and must be kept out of the reach of children. It also includes information on the lot number, expiration date, and NDC/GTIN codes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
